1. 2022
  2. 2021
  3. A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern

    Brinkkemper, M., Brouwer, P. J. M., Maisonnasse, P., Grobben, M., Caniels, T. G., Poniman, M., Burger, J. A., Bontjer, I., Oomen, M., Bouhuijs, J. H., van der Linden, C. A., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., le Grand, R. & Sanders, R. W., 1 Dec 2021, In: npj Vaccines. 6, 1, 146.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

    Maisonnasse, P., Aldon, Y., Marc, A., Marlin, R., Dereuddre-Bosquet, N., Kuzmina, N. A., Freyn, A. W., Snitselaar, J. L., Gonçalves, A., Caniels, T. G., Burger, J. A., Poniman, M., Bontjer, I., Chesnais, V., Diry, S. G., Iershov, A., Ronk, A. J., Jangra, S., Rathnasinghe, R., Brouwer, P. J. M. & 31 others, Bijl, T. P. L., van Schooten, J., Brinkkemper, M., Liu, H., Yuan, M., Mire, C. E., van Breemen, M. J., Contreras, V., Naninck, T., Lemaître, J., Kahlaoui, N., Relouzat, F., Chapon, C., Ho Tsong Fang, R., McDanal, C., Osei-Twum, M., St-Amant, N., Gagnon, L., Montefiori, D. C., Wilson, I. A., Ginoux, E., de Bree, G. J., García-Sastre, A., Schotsaert, M., Coughlan, L., Bukreyev, A., van der Werf, S., Guedj, J. R., Sanders, R. W., van Gils, M. J. & le Grand, R., 1 Dec 2021, In: Nature communications. 12, 1, 6097.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses

    Yin, V., Lai, S-H., Caniels, T. G., Brouwer, P. J. M., Brinkkemper, M., Aldon, Y., Liu, H., Yuan, M., Wilson, I. A., Sanders, R. W., van Gils, M. J. & Heck, A. J. R., 24 Nov 2021, In: ACS central science. 7, 11, p. 1863-1873 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

    Amsterdam UMC COVID-19 S3/HCW study group, 23 Nov 2021, In: eLife. 10, e70330.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

    Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Grobben, M., Claireaux, M., de Gast, M., Marlin, R., Chesnais, V., Diry, S. G., Allen, J. D., Watanabe, Y., Giezen, J. M., Kerster, G., Turner, H. L., van der Straten, K., van der Linden, C. A., Aldon, Y., Naninck, T., Bontjer, I. & 27 others, Burger, J. A., Poniman, M., Mykytyn, A. Z., Okba, N. M. A., Schermer, E. E., van Breemen, M. J., Ravichandran, R., Caniels, T. G., van Schooten, J., Kahlaoui, N., Contreras, V., Lemaître, J., Chapon, C., Fang, R. H. T., Villaudy, J., Sliepen, K., van der Velden, Y. U., Haagmans, B. L., de Bree, G. J., Ginoux, E., Ward, A. B., Crispin, M., King, N. P., van der Werf, S., van Gils, M. J., le Grand, R. & Sanders, R. W., 4 Mar 2021, In: Cell. 184, 5, p. 1188-1200.e19 36 p., 365726.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. 2019
  9. Nanoparticle vaccines for inducing HIV-1 neutralizing antibodies

    Brinkkemper, M. & Sliepen, K., 2019, In: Vaccines. 7, 3, 76.

    Research output: Contribution to journalReview articleAcademicpeer-review

ID: 5194223